Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 144 entries
Sorted by: Best Match Show Resources per page
Outside the Box: Working With Wildlife in Biocontainment.

ILAR journal

Falendysz EA, Calhoun DM, Smith CA, Sleeman JM.
PMID: 34428796
ILAR J. 2022 Jan 07;61(1):72-85. doi: 10.1093/ilar/ilab025.

Research with captive wildlife in Animal Biosafety Level 2 (ABSL2) and 3 (ABSL3) facilities is becoming increasingly necessary as emerging and re-emerging diseases involving wildlife have increasing impacts on human, animal, and environmental health. Utilizing wildlife species in a...

Cite
Falendysz EA, Calhoun DM, Smith CA, et al. Outside the Box: Working With Wildlife in Biocontainment. ILAR J. 2022;61(1):72-85doi: 10.1093/ilar/ilab025.
Falendysz, E. A., Calhoun, D. M., Smith, C. A., & Sleeman, J. M. (2022). Outside the Box: Working With Wildlife in Biocontainment. ILAR journal, 61(1), 72-85. https://doi.org/10.1093/ilar/ilab025
Falendysz, Elizabeth A, et al. "Outside the Box: Working With Wildlife in Biocontainment." ILAR journal vol. 61,1 (2022): 72-85. doi: https://doi.org/10.1093/ilar/ilab025
Falendysz EA, Calhoun DM, Smith CA, Sleeman JM. Outside the Box: Working With Wildlife in Biocontainment. ILAR J. 2022 Jan 07;61(1):72-85. doi: 10.1093/ilar/ilab025. PMID: 34428796.
Copy Download .nbib Format: NLM
Understanding Cybersecurity Threat Trends Through Dynamic Topic Modeling.

Frontiers in big data

Sleeman J, Finin T, Halem M.
PMID: 34268490
Front Big Data. 2021 Jun 29;4:601529. doi: 10.3389/fdata.2021.601529. eCollection 2021.

Cybersecurity threats continue to increase and are impacting almost all aspects of modern life. Being aware of how vulnerabilities and their exploits are changing gives helpful insights into combating new threats. Applying dynamic topic modeling to a time-stamped cybersecurity...

Cite
Sleeman J, Finin T, Halem M. Understanding Cybersecurity Threat Trends Through Dynamic Topic Modeling. Front Big Data. 2021;4:601529doi: 10.3389/fdata.2021.601529.
Sleeman, J., Finin, T., & Halem, M. (2021). Understanding Cybersecurity Threat Trends Through Dynamic Topic Modeling. Frontiers in big data, 4601529. https://doi.org/10.3389/fdata.2021.601529
Sleeman, Jennifer, et al. "Understanding Cybersecurity Threat Trends Through Dynamic Topic Modeling." Frontiers in big data vol. 4 (2021): 601529. doi: https://doi.org/10.3389/fdata.2021.601529
Sleeman J, Finin T, Halem M. Understanding Cybersecurity Threat Trends Through Dynamic Topic Modeling. Front Big Data. 2021 Jun 29;4:601529. doi: 10.3389/fdata.2021.601529. eCollection 2021. PMID: 34268490; PMCID: PMC8275653.
Copy Download .nbib Format: NLM
Second malignancy probabilities in prostate cancer patients treated with SBRT and other contemporary radiation techniques: Reply.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Christopher Dee E, Leeman JE.
PMID: 34774655
Radiother Oncol. 2021 Dec;165:191-192. doi: 10.1016/j.radonc.2021.11.006. Epub 2021 Nov 11.

No abstract available.

Cite
Christopher Dee E, Leeman JE. Second malignancy probabilities in prostate cancer patients treated with SBRT and other contemporary radiation techniques: Reply. Radiother Oncol. 2021;165:191-192doi: 10.1016/j.radonc.2021.11.006.
Christopher Dee, E., & Leeman, J. E. (2021). Second malignancy probabilities in prostate cancer patients treated with SBRT and other contemporary radiation techniques: Reply. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 165191-192. https://doi.org/10.1016/j.radonc.2021.11.006
Christopher Dee, Edward, and Leeman, Jonathan E. "Second malignancy probabilities in prostate cancer patients treated with SBRT and other contemporary radiation techniques: Reply." Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology vol. 165 (2021): 191-192. doi: https://doi.org/10.1016/j.radonc.2021.11.006
Christopher Dee E, Leeman JE. Second malignancy probabilities in prostate cancer patients treated with SBRT and other contemporary radiation techniques: Reply. Radiother Oncol. 2021 Dec;165:191-192. doi: 10.1016/j.radonc.2021.11.006. Epub 2021 Nov 11. PMID: 34774655.
Copy Download .nbib Format: NLM
IER2-induced senescence drives melanoma invasion through osteopontin.

Oncogene

Kyjacova L, Saup R, Rönsch K, Wallbaum S, Dukowic-Schulze S, Foss A, Scherer SD, Rothley M, Neeb A, Grau N, Thiele W, Thaler S, Cremers N, Sticht C, Gretz N, Garvalov BK, Utikal J, Sleeman JP.
PMID: 34611309
Oncogene. 2021 Nov;40(47):6494-6512. doi: 10.1038/s41388-021-02027-6. Epub 2021 Oct 05.

Expression of the immediate-early response gene IER2 has been associated with the progression of several types of cancer, but its functional role is poorly understood. We found that increased IER2 expression in human melanoma is associated with shorter overall...

Cite
Kyjacova L, Saup R, Rönsch K, et al. IER2-induced senescence drives melanoma invasion through osteopontin. Oncogene. 2021;40(47):6494-6512doi: 10.1038/s41388-021-02027-6.
Kyjacova, L., Saup, R., Rönsch, K., Wallbaum, S., Dukowic-Schulze, S., Foss, A., Scherer, S. D., Rothley, M., Neeb, A., Grau, N., Thiele, W., Thaler, S., Cremers, N., Sticht, C., Gretz, N., Garvalov, B. K., Utikal, J., & Sleeman, J. P. (2021). IER2-induced senescence drives melanoma invasion through osteopontin. Oncogene, 40(47), 6494-6512. https://doi.org/10.1038/s41388-021-02027-6
Kyjacova, Lenka, et al. "IER2-induced senescence drives melanoma invasion through osteopontin." Oncogene vol. 40,47 (2021): 6494-6512. doi: https://doi.org/10.1038/s41388-021-02027-6
Kyjacova L, Saup R, Rönsch K, Wallbaum S, Dukowic-Schulze S, Foss A, Scherer SD, Rothley M, Neeb A, Grau N, Thiele W, Thaler S, Cremers N, Sticht C, Gretz N, Garvalov BK, Utikal J, Sleeman JP. IER2-induced senescence drives melanoma invasion through osteopontin. Oncogene. 2021 Nov;40(47):6494-6512. doi: 10.1038/s41388-021-02027-6. Epub 2021 Oct 05. PMID: 34611309; PMCID: PMC8616759.
Copy Download .nbib Format: NLM
Diverse Views in the Assignment of Credit for Research Discoveries.

ACS omega

Seeman JI.
PMID: 35036672
ACS Omega. 2022 Jan 11;7(1):1-4. doi: 10.1021/acsomega.1c04845. eCollection 2022 Jan 11.

No abstract available.

Cite
Seeman JI. Diverse Views in the Assignment of Credit for Research Discoveries. ACS Omega. 2022;7(1):1-4doi: 10.1021/acsomega.1c04845.
Seeman, J. I. (2022). Diverse Views in the Assignment of Credit for Research Discoveries. ACS omega, 7(1), 1-4. https://doi.org/10.1021/acsomega.1c04845
Seeman, Jeffrey I. "Diverse Views in the Assignment of Credit for Research Discoveries." ACS omega vol. 7,1 (2022): 1-4. doi: https://doi.org/10.1021/acsomega.1c04845
Seeman JI. Diverse Views in the Assignment of Credit for Research Discoveries. ACS Omega. 2022 Jan 11;7(1):1-4. doi: 10.1021/acsomega.1c04845. eCollection 2022 Jan 11. PMID: 35036672; PMCID: PMC8757345.
Copy Download .nbib Format: NLM
Aligning implementation science with improvement practice: a call to action.

Implementation science communications

Leeman J, Rohweder C, Lee M, Brenner A, Dwyer A, Ko LK, O'Leary MC, Ryan G, Vu T, Ramanadhan S.
PMID: 34496978
Implement Sci Commun. 2021 Sep 08;2(1):99. doi: 10.1186/s43058-021-00201-1.

BACKGROUND: In several recent articles, authors have called for aligning the fields of implementation and improvement science. In this paper, we call for implementation science to also align with improvement practice. Multiple implementation scholars have highlighted the importance of...

Cite
Leeman J, Rohweder C, Lee M, et al. Aligning implementation science with improvement practice: a call to action. Implement Sci Commun. 2021;2(1):99doi: 10.1186/s43058-021-00201-1.
Leeman, J., Rohweder, C., Lee, M., Brenner, A., Dwyer, A., Ko, L. K., O'Leary, M. C., Ryan, G., Vu, T., & Ramanadhan, S. (2021). Aligning implementation science with improvement practice: a call to action. Implementation science communications, 2(1), 99. https://doi.org/10.1186/s43058-021-00201-1
Leeman, Jennifer, et al. "Aligning implementation science with improvement practice: a call to action." Implementation science communications vol. 2,1 (2021): 99. doi: https://doi.org/10.1186/s43058-021-00201-1
Leeman J, Rohweder C, Lee M, Brenner A, Dwyer A, Ko LK, O'Leary MC, Ryan G, Vu T, Ramanadhan S. Aligning implementation science with improvement practice: a call to action. Implement Sci Commun. 2021 Sep 08;2(1):99. doi: 10.1186/s43058-021-00201-1. PMID: 34496978; PMCID: PMC8424169.
Copy Download .nbib Format: NLM
RASSF1A Suppresses Estrogen-Dependent Breast Cancer Cell Growth through Inhibition of the Yes-Associated Protein 1 (YAP1), Inhibition of the Forkhead Box Protein M1 (FOXM1), and Activation of Forkhead Box Transcription Factor 3A (FOXO3A).

Cancers

Roßwag S, Thiede G, Sleeman JP, Thaler S.
PMID: 32967092
Cancers (Basel). 2020 Sep 21;12(9). doi: 10.3390/cancers12092689.

The estrogen receptor alpha (ERα) is expressed by the majority of breast cancers and plays an important role in breast cancer development and tumor outgrowth. Although ERα is well known to be a specific and efficient therapeutic target, the...

Cite
Roßwag S, Thiede G, Sleeman JP, et al. RASSF1A Suppresses Estrogen-Dependent Breast Cancer Cell Growth through Inhibition of the Yes-Associated Protein 1 (YAP1), Inhibition of the Forkhead Box Protein M1 (FOXM1), and Activation of Forkhead Box Transcription Factor 3A (FOXO3A). Cancers (Basel). 2020;12(9)doi: 10.3390/cancers12092689.
Roßwag, S., Thiede, G., Sleeman, J. P., & Thaler, S. (2020). RASSF1A Suppresses Estrogen-Dependent Breast Cancer Cell Growth through Inhibition of the Yes-Associated Protein 1 (YAP1), Inhibition of the Forkhead Box Protein M1 (FOXM1), and Activation of Forkhead Box Transcription Factor 3A (FOXO3A). Cancers, 12(9), . https://doi.org/10.3390/cancers12092689
Roßwag, Sven, et al. "RASSF1A Suppresses Estrogen-Dependent Breast Cancer Cell Growth through Inhibition of the Yes-Associated Protein 1 (YAP1), Inhibition of the Forkhead Box Protein M1 (FOXM1), and Activation of Forkhead Box Transcription Factor 3A (FOXO3A)." Cancers vol. 12,9 (2020). doi: https://doi.org/10.3390/cancers12092689
Roßwag S, Thiede G, Sleeman JP, Thaler S. RASSF1A Suppresses Estrogen-Dependent Breast Cancer Cell Growth through Inhibition of the Yes-Associated Protein 1 (YAP1), Inhibition of the Forkhead Box Protein M1 (FOXM1), and Activation of Forkhead Box Transcription Factor 3A (FOXO3A). Cancers (Basel). 2020 Sep 21;12(9). doi: 10.3390/cancers12092689. PMID: 32967092; PMCID: PMC7566002.
Copy Download .nbib Format: NLM
The Nozoe Autograph Books: "It ain't over 'til it's over".

Chemical record (New York, N.Y.)

Seeman JI, Johnson BP.
PMID: 25690992
Chem Rec. 2015 Feb;15(1):412-8. doi: 10.1002/tcr.201500002.

All are welcome! This issue contains the final of the 15 segments of the original Nozoe Autograph Books. But this project couldn't just stop here. A modern extension of the autograph books-a 16(th) segment-will be published and will include...

Cite
Seeman JI, Johnson BP. The Nozoe Autograph Books: "It ain't over 'til it's over". Chem Rec. 2015;15(1):412-8doi: 10.1002/tcr.201500002.
Seeman, J. I., & Johnson, B. P. (2015). The Nozoe Autograph Books: "It ain't over 'til it's over". Chemical record (New York, N.Y.), 15(1), 412-8. https://doi.org/10.1002/tcr.201500002
Seeman, Jeffrey I, and Johnson, Brian P. "The Nozoe Autograph Books: "It ain't over 'til it's over"." Chemical record (New York, N.Y.) vol. 15,1 (2015): 412-8. doi: https://doi.org/10.1002/tcr.201500002
Seeman JI, Johnson BP. The Nozoe Autograph Books: "It ain't over 'til it's over". Chem Rec. 2015 Feb;15(1):412-8. doi: 10.1002/tcr.201500002. PMID: 25690992.
Copy Download .nbib Format: NLM
Data-Powered Participatory Decision Making: Leveraging Systems Thinking and Simulation to Guide Selection and Implementation of Evidence-Based Colorectal Cancer Screening Interventions.

Cancer journal (Sudbury, Mass.)

Wheeler SB, Leeman J, Hassmiller Lich K, Tangka FKL, Davis MM, Richardson LC.
PMID: 29794539
Cancer J. 2018 May/Jun;24(3):136-143. doi: 10.1097/PPO.0000000000000317.

A robust evidence base supports the effectiveness of timely colorectal cancer (CRC) screening, follow-up of abnormal results, and referral to care in reducing CRC morbidity and mortality. However, only two-thirds of the US population is current with recommended screening,...

Cite
Wheeler SB, Leeman J, Hassmiller Lich K, et al. Data-Powered Participatory Decision Making: Leveraging Systems Thinking and Simulation to Guide Selection and Implementation of Evidence-Based Colorectal Cancer Screening Interventions. Cancer J. 2018;24(3):136-143doi: 10.1097/PPO.0000000000000317.
Wheeler, S. B., Leeman, J., Hassmiller Lich, K., Tangka, F. K. L., Davis, M. M., & Richardson, L. C. (2018). Data-Powered Participatory Decision Making: Leveraging Systems Thinking and Simulation to Guide Selection and Implementation of Evidence-Based Colorectal Cancer Screening Interventions. Cancer journal (Sudbury, Mass.), 24(3), 136-143. https://doi.org/10.1097/PPO.0000000000000317
Wheeler, Stephanie B, et al. "Data-Powered Participatory Decision Making: Leveraging Systems Thinking and Simulation to Guide Selection and Implementation of Evidence-Based Colorectal Cancer Screening Interventions." Cancer journal (Sudbury, Mass.) vol. 24,3 (2018): 136-143. doi: https://doi.org/10.1097/PPO.0000000000000317
Wheeler SB, Leeman J, Hassmiller Lich K, Tangka FKL, Davis MM, Richardson LC. Data-Powered Participatory Decision Making: Leveraging Systems Thinking and Simulation to Guide Selection and Implementation of Evidence-Based Colorectal Cancer Screening Interventions. Cancer J. 2018 May/Jun;24(3):136-143. doi: 10.1097/PPO.0000000000000317. PMID: 29794539; PMCID: PMC6047526.
Copy Download .nbib Format: NLM
Stereotactic radiosurgery for the treatment and palliation of base of skull metastases.

Journal of radiosurgery and SBRT

Clump DA, Leeman JE, Wegner RE, Burton SA, Mintz AH, Heron DE.
PMID: 29296364
J Radiosurg SBRT. 2013;2(3):217-223.

OBJECTIVES: Patients with skullbase metastases often present with evolving cranial nerve deficits, pain and advanced systemic disease. These factors along with declining performance status limit invasive interventions; yet, a safe, efficient treatment modality that augments palliative efforts is desirable....

Cite
Clump DA, Leeman JE, Wegner RE, et al. Stereotactic radiosurgery for the treatment and palliation of base of skull metastases. J Radiosurg SBRT. 2013;2(3):217-223
Clump, D. A., Leeman, J. E., Wegner, R. E., Burton, S. A., Mintz, A. H., & Heron, D. E. (2013). Stereotactic radiosurgery for the treatment and palliation of base of skull metastases. Journal of radiosurgery and SBRT, 2(3), 217-223.
Clump, David A, et al. "Stereotactic radiosurgery for the treatment and palliation of base of skull metastases." Journal of radiosurgery and SBRT vol. 2,3 (2013): 217-223.
Clump DA, Leeman JE, Wegner RE, Burton SA, Mintz AH, Heron DE. Stereotactic radiosurgery for the treatment and palliation of base of skull metastases. J Radiosurg SBRT. 2013;2(3):217-223. PMID: 29296364; PMCID: PMC5658813.
Copy Download .nbib Format: NLM
Extended publication guidelines for the reporting of clinical research in Clinical and Experimental Metastasis.

Clinical & experimental metastasis

Haier J, Sleeman JP.
PMID: 29516209
Clin Exp Metastasis. 2017 Dec;34(8):441-442. doi: 10.1007/s10585-018-9879-9. Epub 2018 Mar 07.

No abstract available.

Cite
Haier J, Sleeman JP. Extended publication guidelines for the reporting of clinical research in Clinical and Experimental Metastasis. Clin Exp Metastasis. 2018;34(8):441-442doi: 10.1007/s10585-018-9879-9.
Haier, J., & Sleeman, J. P. (2017). Extended publication guidelines for the reporting of clinical research in Clinical and Experimental Metastasis. Clinical & experimental metastasis, 34(8), 441-442. https://doi.org/10.1007/s10585-018-9879-9
Haier, Jörg, and Sleeman, Jonathan P. "Extended publication guidelines for the reporting of clinical research in Clinical and Experimental Metastasis." Clinical & experimental metastasis vol. 34,8 (2017): 441-442. doi: https://doi.org/10.1007/s10585-018-9879-9
Haier J, Sleeman JP. Extended publication guidelines for the reporting of clinical research in Clinical and Experimental Metastasis. Clin Exp Metastasis. 2017 Dec;34(8):441-442. doi: 10.1007/s10585-018-9879-9. Epub 2018 Mar 07. PMID: 29516209.
Copy Download .nbib Format: NLM
Introduction to "preventing healthcare-associated infections: results and lessons learned from AHRQ's HAI program".

Infection control and hospital epidemiology

Battles JB, Cleeman JI, Kahn KL, Weinberg DA.
PMID: 25222887
Infect Control Hosp Epidemiol. 2014 Oct;35:S1-2. doi: 10.1086/677817.

No abstract available.

Cite
Battles JB, Cleeman JI, Kahn KL, et al. Introduction to "preventing healthcare-associated infections: results and lessons learned from AHRQ's HAI program". Infect Control Hosp Epidemiol. 2014;35:S1-2doi: 10.1086/677817.
Battles, J. B., Cleeman, J. I., Kahn, K. L., & Weinberg, D. A. (2014). Introduction to "preventing healthcare-associated infections: results and lessons learned from AHRQ's HAI program". Infection control and hospital epidemiology, 35S1-2. https://doi.org/10.1086/677817
Battles, James B, et al. "Introduction to "preventing healthcare-associated infections: results and lessons learned from AHRQ's HAI program"." Infection control and hospital epidemiology vol. 35 (2014): S1-2. doi: https://doi.org/10.1086/677817
Battles JB, Cleeman JI, Kahn KL, Weinberg DA. Introduction to "preventing healthcare-associated infections: results and lessons learned from AHRQ's HAI program". Infect Control Hosp Epidemiol. 2014 Oct;35:S1-2. doi: 10.1086/677817. PMID: 25222887.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 144 entries